Welllll loooks like I was right on my price target. I guess you know who is more credible on price predictions now when it comes to this board.
But I was wrong here as well.
The court case did give USRM a PR rep and now it appears this company is in smoldering ashes from the FDA and all the claims/suits.
But now... no one has said a thing about the position this company is in. Greedy hands don't often speak of their moves... so I guess I'll introduce the elephant in the room.
USRM has no audited reports, so what is Miguel's word really worth? is he signing the truth on his SEC reports? is it just him compiling these reports on his own, from a remote login? could be.. but either way...
USRM has successfully given the FDA case law to now pounce and prohibit physicians in the U.S. from using the adipose stem procedure. Out of all the cases showing the procedure does work for serious conditions which no pharma company can compare.. let's just say the FDA screwed up a lot of lives on this one. In my neighborhood, a child was awaiting a stem cell injection into her pancreas, as the latest evidence has shown this has been curing diabetes. But let's just worry about the lady that went blind after the procedure when she was going blind (did that make sense?). Forget about the ones that can be saved which outnumber 1000 to 1?
So now USRM is positioned as far as we can see (per management)... that they may be the most qualified and most readily positioned entity to submit a stem cell biologic NDA.
SO to USRM, the move is NAD+ injections or first stem cell approved biologic drug for maybe.. myocarditis (the disease resulting from the Covid-19 vax), or how about another heart condition?
Banks won't touch this stock, so I'm in 10-fold at .008.
You can say BK all day.. but realistically why didn't they do that years ago? you have to give these shysters some credit, the more lucrative scam is to keep this dog n pony show going.
